|
FR2505657A1
(fr)
|
1981-05-13 |
1982-11-19 |
Pasteur Institut |
Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
|
|
US5626851A
(en)
|
1987-11-30 |
1997-05-06 |
The Wistar Institute Of Anatomy And Biology |
Rotavirus reassortant vaccine
|
|
US5096885A
(en)
|
1988-04-15 |
1992-03-17 |
Genentech, Inc. |
Human growth hormone formulation
|
|
EP0410207B1
(en)
|
1989-07-24 |
1997-01-22 |
Bayer Corporation |
Stabilization of highly purified proteins
|
|
DK0713397T3
(da)
|
1992-03-24 |
2003-03-31 |
United Cancer Res Inst |
Vaccine indeholdende levende virus
|
|
AU2088992A
(en)
|
1992-05-05 |
1993-11-11 |
Research Foundation For Microbial Diseases Of Osaka University, The |
Stabilized live vaccine
|
|
CA2158935A1
(en)
|
1993-10-12 |
1995-04-20 |
Chiron Viagene, Inc. |
Methods for preserving recombinant viruses
|
|
ATE328068T1
(de)
|
1994-05-16 |
2006-06-15 |
Merck & Co Inc |
Papillomavirus vakzine
|
|
WO1996001651A1
(en)
|
1994-07-11 |
1996-01-25 |
The Government Of The United States Of America, Represented By The Department Of Health And Human Services |
Attenuated human rotavirus vaccine
|
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
CA2226575C
(en)
|
1995-07-27 |
2011-10-18 |
Genentech, Inc. |
Stabile isotonic lyophilized protein formulation
|
|
GB9521806D0
(en)
|
1995-10-25 |
1996-01-03 |
Cortecs Ltd |
Preservation methods
|
|
US6165773A
(en)
|
1995-10-25 |
2000-12-26 |
Provalis Uk Limited |
Methods of preserving viruses
|
|
FR2742756B1
(fr)
|
1995-12-22 |
1998-04-03 |
Pasteur Merieux Serums Vacc |
Stabilisants pour vaccins vivants, vaccins les contenant et procedes pour leur preparation
|
|
FR2751343B1
(fr)
|
1996-07-16 |
1998-12-18 |
Transgene Sa |
Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament
|
|
EP1891968A3
(en)
|
1996-09-26 |
2008-09-03 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
|
US6403098B1
(en)
|
1996-09-26 |
2002-06-11 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
|
US6616931B1
(en)
|
1996-09-26 |
2003-09-09 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
|
US5932223A
(en)
*
|
1996-09-26 |
1999-08-03 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
|
US7732129B1
(en)
|
1998-12-01 |
2010-06-08 |
Crucell Holland B.V. |
Method for the production and purification of adenoviral vectors
|
|
US6544769B1
(en)
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
|
US20080261289A1
(en)
|
1996-12-13 |
2008-10-23 |
Schering-Plough Corporation |
Compositions comprising viruses and methods for concentrating virus preparations
|
|
US6290967B1
(en)
|
1996-12-20 |
2001-09-18 |
Merck & Co., Inc. |
Stabilizers for lyophilized vaccines
|
|
JP2000507963A
(ja)
|
1996-12-20 |
2000-06-27 |
メルク エンド カンパニー インコーポレーテッド |
凍結乾燥ワクチン用安定剤
|
|
US6051238A
(en)
|
1996-12-20 |
2000-04-18 |
Merck & Co., Inc. |
Stabilizers for lyophilized mumps vaccines
|
|
US6565831B1
(en)
|
1999-02-24 |
2003-05-20 |
Oncolytics Biotech Inc. |
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
|
|
WO1999041416A2
(en)
|
1998-02-17 |
1999-08-19 |
Schering Corporation |
Compositions comprising viruses and methods for concentrating virus preparations
|
|
GB9808922D0
(en)
|
1998-04-24 |
1998-06-24 |
Cantab Pharmaceuticals Res Ltd |
Virus preparations
|
|
DE69929443T2
(de)
|
1998-07-28 |
2006-07-27 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Multivalenter human-boviner rotavirus-impfstoff
|
|
CN1062770C
(zh)
*
|
1998-11-12 |
2001-03-07 |
卫生部长春生物制品研究所 |
甲肝-麻疹二联疫苗及其生产方法
|
|
ES2323991T3
(es)
|
1998-11-16 |
2009-07-28 |
Introgen Therapeutics, Inc. |
Formulacion de adenovirus para terapia genica.
|
|
US6689600B1
(en)
*
|
1998-11-16 |
2004-02-10 |
Introgen Therapeutics, Inc. |
Formulation of adenovirus for gene therapy
|
|
US6225289B1
(en)
|
1998-12-10 |
2001-05-01 |
Genvec, Inc. |
Methods and compositions for preserving adenoviral vectors
|
|
WO2000061184A2
(en)
|
1999-04-08 |
2000-10-19 |
Glenn Gregory M |
Dry formulation for transcutaneous immunization
|
|
HUP0202537A3
(en)
|
1999-08-24 |
2004-05-28 |
Teva Pharma |
A vaccine composition and method of using the same
|
|
US6592869B2
(en)
|
1999-08-24 |
2003-07-15 |
Teva Pharmaceutical Industries, Ltd. |
Vaccine composition and method of using the same
|
|
MXPA02004193A
(es)
|
1999-10-29 |
2002-12-13 |
Inhale Therapeutic Syst |
Composiciones de polvo seco que tienen caracteristicas de dispersion mejoradas.
|
|
US7456009B2
(en)
*
|
2000-03-07 |
2008-11-25 |
Merck & Co., Inc. |
Adenovirus formulations
|
|
CA2799545A1
(en)
|
2000-03-07 |
2001-09-13 |
Merck Sharp & Dohme Corp. |
Adenovirus formulations
|
|
US20020120228A1
(en)
|
2000-06-08 |
2002-08-29 |
Yuh-Fun Maa |
Powder compositions
|
|
KR20030020294A
(ko)
|
2000-06-08 |
2003-03-08 |
파우더젝트 백신, 인코포레이티드 |
분말 조성물
|
|
US6689353B1
(en)
*
|
2000-06-28 |
2004-02-10 |
Bayer Pharmaceuticals Corporation |
Stabilized interleukin 2
|
|
TWI289158B
(en)
|
2000-08-10 |
2007-11-01 |
Oncolytics Biotech Inc |
Method of producing infectious reovirus
|
|
GB0020089D0
(en)
|
2000-08-15 |
2000-10-04 |
Smithkline Beecham Biolog |
Vaccine Composition
|
|
ES2327103T3
(es)
|
2000-09-25 |
2009-10-26 |
Polymun Scientific Immunbiologische Forschung Gmbh |
Vacuna viva de influenzavirus y procedimiento de fabricacion.
|
|
US20040033239A1
(en)
|
2001-03-06 |
2004-02-19 |
Evans Robert K |
Adenovirus formulations
|
|
DK2253701T3
(da)
|
2001-03-16 |
2014-10-20 |
Oncolytics Biotech Inc |
Fremgangsmåde til ekstraktion af en virus fra en cellekultur
|
|
EP1399131A2
(en)
|
2001-06-08 |
2004-03-24 |
Powderject Vaccines, Inc. |
Spray freeze-dried compositions
|
|
GB0124710D0
(en)
|
2001-10-15 |
2001-12-05 |
Quadrant Healthcare Uk Ltd |
Therapeutic composition
|
|
CA2466982A1
(en)
|
2001-11-19 |
2003-05-30 |
Becton, Dickinson And Company |
Pharmaceutical compositions in particulate form
|
|
CA2469623C
(en)
|
2001-12-12 |
2012-05-29 |
F H Faulding & Co Limited |
Composition for the preservation of viruses
|
|
US20030153065A1
(en)
|
2002-01-14 |
2003-08-14 |
Genvec, Inc. |
Composition and method for maintaining non-enveloped viral vectors
|
|
CA2469721A1
(en)
|
2002-01-18 |
2003-07-31 |
Schering Aktiengesellschaft |
Stabilized formulations of adenovirus
|
|
AU2003234090A1
(en)
|
2002-04-11 |
2003-10-27 |
Medimmune Vaccines, Inc. |
Spray freeze dry of compositions for pulmonary administration
|
|
WO2003087327A2
(en)
|
2002-04-11 |
2003-10-23 |
Medimmune Vaccines, Inc. |
Preservation of bioactive materials by freeze dried foam
|
|
AU2003230908A1
(en)
|
2002-04-11 |
2003-10-27 |
Medimmune Vaccines, Inc. |
Spray freeze dry of compositions for intranasal administration
|
|
JP2005523722A
(ja)
|
2002-04-30 |
2005-08-11 |
オンコリティクス バイオテック， インコーポレイティッド |
改善されたウイルス精製方法
|
|
MXPA05004528A
(es)
|
2002-11-01 |
2005-07-26 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica.
|
|
US6752740B2
(en)
|
2002-11-12 |
2004-06-22 |
Jeffery T. Semmes |
Continuously variable transmission
|
|
KR20100107083A
(ko)
|
2002-12-17 |
2010-10-04 |
메디뮨 엘엘씨 |
생물활성 물질의 고압 분무 건조
|
|
US6931888B2
(en)
|
2003-02-07 |
2005-08-23 |
Ferro Corporation |
Lyophilization method and apparatus for producing particles
|
|
NZ543467A
(en)
|
2003-04-10 |
2008-07-31 |
Novartis Vaccines & Diagnostic |
The severe acute respiratory syndrome coronavirus
|
|
EP2272532B1
(en)
|
2003-09-02 |
2016-02-10 |
GlaxoSmithKline Biologicals S.A. |
Rotavirus vaccine
|
|
WO2005052116A2
(en)
|
2003-11-19 |
2005-06-09 |
Merck & Co., Inc. |
Preservative-containing virus formulations
|
|
BRPI0417672A
(pt)
|
2003-12-17 |
2007-03-20 |
Wyeth Corp |
processos para produzir composições de vìrus estáveis em armazenamento, composições de vìrus e imunogênicas
|
|
WO2005066333A1
(en)
|
2003-12-30 |
2005-07-21 |
Aventis Pasteur, Inc. |
Stabilizing compositions for recombinant viruses
|
|
GB0404586D0
(en)
|
2004-03-01 |
2004-04-07 |
Britannia Pharmaceuticals Ltd |
Improvements in or relating to organic materials
|
|
AU2005225000A1
(en)
|
2004-03-04 |
2005-09-29 |
Wyeth |
Lyophilization method to improve excipient crystallization
|
|
EP2567708A3
(en)
|
2004-06-02 |
2013-10-16 |
Victor Bronshtein |
Preservation by vaporization
|
|
WO2006029467A1
(en)
|
2004-09-16 |
2006-03-23 |
Btf Pty Ltd |
Rapid freeze drying process
|
|
JP2008514644A
(ja)
|
2004-09-28 |
2008-05-08 |
アルザ コーポレイション |
ミョウバンアジュバント免疫活性剤の安定化
|
|
ES2633471T3
(es)
*
|
2004-10-06 |
2017-09-21 |
Medimmune, Llc |
Composiciones de vacuna contra la gripe estables a temperatura de refrigerador
|
|
US7901921B2
(en)
|
2004-10-22 |
2011-03-08 |
Oncolytics Biotech Inc. |
Viral purification methods
|
|
JP5110696B2
(ja)
*
|
2004-11-05 |
2012-12-26 |
ウェルスタット バイオロジクス コーポレイション |
安定かつ濾過可能なエンベロープで覆われたウイルス処方物
|
|
WO2006061708A2
(en)
|
2004-12-09 |
2006-06-15 |
Precimed S.A. |
Surgical tool holder for facilitated sterilization
|
|
US20060141483A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Calton Gary J |
Stabilization of viral compositions
|
|
WO2006089290A1
(en)
*
|
2005-02-18 |
2006-08-24 |
Abraxis Bioscience Inc.. |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
ATE523207T1
(de)
*
|
2005-09-16 |
2011-09-15 |
Merial Ltd |
Stabilisatoren für gefriergetrocknete impfstoffe
|
|
CN1765181A
(zh)
*
|
2005-10-19 |
2006-05-03 |
路兴波 |
高效抗病毒制剂
|
|
ATE539149T1
(de)
|
2006-04-20 |
2012-01-15 |
Wyeth Llc |
Reinigungsverfahren zur isolierung von gereinigtem vesikulärem stomatitisvirus aus zellkultur
|
|
US9283260B2
(en)
|
2006-04-21 |
2016-03-15 |
Amgen Inc. |
Lyophilized therapeutic peptibody formulations
|
|
EP1854478A1
(en)
|
2006-05-12 |
2007-11-14 |
Cytos Biotechnology AG |
Nicotine-carrier vaccine formulation
|
|
EP1878791A1
(en)
|
2006-07-11 |
2008-01-16 |
Bia Separations D.O.O. |
Method for influenza virus purification
|
|
CN101557824B
(zh)
|
2006-08-07 |
2012-01-25 |
财团法人化学及血清疗法研究所 |
活牛痘疫苗的制备方法
|
|
AU2007300221A1
(en)
|
2006-09-25 |
2008-04-03 |
Medimmune, Llc. |
Stabilized antibody formulations and uses thereof
|
|
CA2668417A1
(en)
|
2006-11-03 |
2008-05-15 |
Alphavax, Inc. |
Alphavirus and alphavirus replicon particle formulations and methods
|
|
CA2668834C
(en)
*
|
2006-11-07 |
2016-10-11 |
Sanofi Pasteur Biologics Co. |
Stabilization of vaccines by lyophilization
|
|
HUE062920T2
(hu)
*
|
2006-12-27 |
2023-12-28 |
Zoetis Services Llc |
Eljárások vakcina beadására
|
|
WO2008106646A2
(en)
|
2007-03-01 |
2008-09-04 |
Introgen Therapeutics, Inc |
Methods and formulations for topical gene therapy
|
|
JP5577103B2
(ja)
*
|
2007-03-12 |
2014-08-20 |
オンコリティクス バイオテク，インコーポレーテッド |
改変配列を有するレオウイルス
|
|
GB0705245D0
(en)
|
2007-03-19 |
2007-04-25 |
Stabilitech Ltd |
Stable biological products
|
|
EP2829282B1
(en)
|
2007-03-22 |
2017-10-25 |
The Regents of The University of Colorado, A Body Corporate |
Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
|
|
SI2144998T1
(sl)
|
2007-04-06 |
2017-05-31 |
Takeda Vaccines, Inc. |
Postopki in sestavki za žive atenuirane viruse
|
|
AR066649A1
(es)
|
2007-05-21 |
2009-09-02 |
Oncolytics Biotech Inc |
Reovirus mutantes y metodos de elaboracion y uso de los mismos
|
|
EP2197283B1
(en)
|
2007-09-25 |
2013-07-17 |
Aridis Pharmaceuticals |
Formulations for preservation of rota virus
|
|
CA2917512C
(en)
*
|
2007-10-12 |
2025-08-05 |
President And Fellows Of Harvard College |
VACCINE NANOTECHNOLOGY
|
|
WO2009056651A1
(en)
|
2007-11-02 |
2009-05-07 |
Cytos Biotechnology Ag |
Angiotensin-carrier formulation
|
|
EP2220116B1
(en)
|
2007-11-12 |
2012-09-05 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
US8227577B2
(en)
|
2007-12-21 |
2012-07-24 |
Hoffman-La Roche Inc. |
Bivalent, bispecific antibodies
|
|
WO2009108689A1
(en)
|
2008-02-25 |
2009-09-03 |
Novavax, Inc. |
Sugar glassified virus like particles (vlps)
|
|
WO2009133413A1
(en)
|
2008-04-28 |
2009-11-05 |
Novatech D.O.O. |
Formulation based on micronized clinoptilolite as a therapeutic agent for removal of toxins, bacteria and viruses from organism
|
|
LT2805731T
(lt)
*
|
2009-09-03 |
2019-02-11 |
Ablynx N.V. |
Stabilios polipeptidų kompozicijos ir jų panaudojimas
|
|
CN103269716B
(zh)
*
|
2010-12-02 |
2015-05-27 |
昂科利蒂克斯生物科技公司 |
冻干病毒制剂
|
|
WO2012075379A2
(en)
|
2010-12-02 |
2012-06-07 |
Oncolytics Biotech Inc. |
Liquid viral formulations
|
|
MX337348B
(es)
*
|
2011-04-29 |
2016-02-29 |
Oncolytics Biotech Inc |
Metodos para purificar virus utilizando cromatografia de permeacion en gel.
|
|
JP6065096B2
(ja)
|
2015-12-25 |
2017-01-25 |
ダイキン工業株式会社 |
調湿装置
|